rs727503024
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_000501.4(ELN):c.435delG(p.Leu146CysfsTer37) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. G145G) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000501.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- cutis laxa, autosomal dominant 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, Genomics England PanelApp, G2P
- supravalvular aortic stenosisInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
- autosomal dominant cutis laxaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial thoracic aortic aneurysm and aortic dissectionInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ELN | NM_000501.4 | c.435delG | p.Leu146CysfsTer37 | frameshift_variant | Exon 9 of 33 | ENST00000252034.12 | NP_000492.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ELN | ENST00000252034.12 | c.435delG | p.Leu146CysfsTer37 | frameshift_variant | Exon 9 of 33 | 1 | NM_000501.4 | ENSP00000252034.7 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Supravalvar aortic stenosis Pathogenic:1
The p.Leu146fs variant in ELN has been identified by our laboratory in 1 individ ual with SVAS as well as 1 affected family member. It was absent from large pop ulation studies. This variant is predicted to alter the protein?s amino acid seq uence beginning at position 146 and lead to a premature termination codon 37 ami no acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Pathogenic truncating variant in the ELN gene are common in ind ividuals with SVAS (Human Gene Mutation Database, HGMD and LMM, unpublished data ). In summary, this variant meets our criteria to be classified as pathogenic fo r SVAS in an autosomal dominant manner based upon absence from controls and the predicted impact to the protein. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at